Stock comparison
Lantheus Holdings
ResMed
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LNTH
Lantheus Holdings
Market cap
$6.71B
Sector
Healthcare
RMD
ResMed
Market cap
$30.18B
Sector
Healthcare
Overall winner
ResMed RMD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LNTH | RMD | Winner |
|---|---|---|---|
| Warren Buffett | 61C | 72B | RMD |
| Benjamin Graham | 60D | 75B | RMD |
| Philip Fisher | 61C | 75B | RMD |
| Peter Lynch | 77B | 58C | LNTH |
| Joel Greenblatt | 41D | 47D | RMD |
| Charlie Munger | 52D | 69B | RMD |
| Terry Smith | 57D | 73B | RMD |
Side-by-side metrics
| Metric | LNTH | RMD |
|---|---|---|
| Market cap | $6.71B | $30.18B |
| P/E (TTM) | 22.3x | 19.6x |
| EV/EBIT | 18.6x | 17.1x |
| ROIC (TTM) | 10.75% | 19.63% |
| Gross margin | 60.48% | 61.69% |
| Net margin | 18.05% | 27.44% |
| Revenue CAGR 5y | 37.99% | 12.64% |
| EPS CAGR 5y | - | 30.73% |
| Debt / Equity | 0.0x | 0.1x |
| Dividend yield | 0.0% | 1.14% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LNTH leads on
- Debt / Equity0.0xvs 0.1x+99%
- Revenue CAGR 5y37.99%vs 12.64%+67%
RMD leads on
- Dividend yield1.14%vs 0.0%+100%
- Market cap$30.18Bvs $6.71B+78%
- ROIC (TTM)19.63%vs 10.75%+45%
- Net margin27.44%vs 18.05%+34%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.